Bulletin
Investor Alert

Edesa Biotech Inc.

NAS: EDSA

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Edesa Biotech Inc.

After Hours

 --Quotes are delayed by 20 min

Jun 9, 2023, 5:53 p.m.

EDSA
/zigman2/quotes/200172674/composite

$

0.90

Change

-0.0023 -0.26%

Volume

Volume 9,086

Quotes are delayed by 20 min

/zigman2/quotes/200172674/composite

Previous close

$ 0.87

$ 0.90

Change

+0.03 +3.90%

Day low

Day high

$0.85

$0.92

Open

52 week low

52 week high

$0.76

$2.81

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Edesa Biotech Inc.

View Ratios
Fiscal year is October-September. All values USD millions. 20182019202020212022 5-year trend
Sales/Revenue 211,849547,825328,801--
Cost of Goods Sold (COGS) incl. D&A 445,320135,04875,164118,788118,188
COGS excluding D&A 256,948128,67617,601--
Depreciation & Amortization Expense 188,3726,37257,563118,788118,188
Depreciation 188,3726,372-17,61617,016
Amortization of Intangibles ---101,172101,172
Gross Income (233,471)412,778253,637(118,788)(118,188)
20182019202020212022 5-year trend
SG&A Expense 4.84M4.19M6.65M23.56M18.25M
Research & Development 2.09M1.46M3.33M17.95M13.34M
Other SG&A 2.76M2.73M3.33M5.62M4.92M
Other Operating Expense -----
Unusual Expense ---(10.34M)(780,257)
EBIT after Unusual Expense ---(13.34M)(17.59M)
Non Operating Income/Expense (35,060)(1,910)(370)(13,020)(21,110)
Non-Operating Interest Income 75,16075,78637,77811,16563,523
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (5.04M)(3.7M)(6.36M)(13.34M)(17.55M)
Income Tax 800-800800800
Income Tax - Current Domestic (1.13M)-800800800
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic (904,400)----
Income Tax - Deferred Foreign 2.04M----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (5.04M)(3.7M)(6.36M)(13.34M)(17.55M)
Minority Interest Expense -----
Net Income (5.04M)(3.7M)(6.36M)(13.34M)(17.55M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (5.04M)(3.7M)(6.36M)(13.34M)(17.55M)
Preferred Dividends -----
Net Income Available to Common (5.04M)(3.7M)(6.36M)(13.34M)(17.55M)
EPS (Basic) (10.54)(0.74)(0.74)(1.10)(1.05)
Basic Shares Outstanding 478,2295.04M8.61M12.08M16.66M
EPS (Diluted) (10.54)(0.74)(0.74)(1.10)(1.05)
Diluted Shares Outstanding 478,2295.04M8.61M12.08M16.66M
EBITDA (4.89M)(3.77M)(6.34M)(23.56M)(18.25M)
Copyright 2023 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.